Director, Breast Medical Oncology Program, Taussig Cancer Institute, Co-Director, Comprehensive Breast Cancer Program
Cleveland Clinic, Cleveland, OH
Oncology
Doctor Jame Abraham, MD practices Oncology. He went to Calicut Medical College. He received 36 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Certificate for one of Highest Accruing Principal Investigators in the Country, CTEP", "America's Top Doctors for Cancer", "Nominated as Outstanding Faculty of the Year Award", "Selected to the Gold Human Honor Society (GHHS)", ""Pink Tie Guy"", "Dean's Award for Excellence in Clinical Medicine", "Quality Award (Customer Satisfaction)", "President of India, Her Excellency, Smt. Pratibha Patil "Vaidya Bhooshan"", "Deans award for excellence in patient care", "Bonnie Wells Wilson Eminent Scholar and Distinguished Professor in Breast Cancer Research", "Best in the Class", "First Bonnie Wells Wilson Distinguished Professor and Eminent Scholar in Breast Cancer Research", "Outstanding Achievement in Medicine", "Outstanding Faculty Award", "Listed in Best Doctors in America", "STAR Award for Customer Service", "Clinician of the Year Award", "Volunteer of the Year Award for the State of West Virginia", "Selected as one of the "Top Ten Employees"", "Nominated for the Outstanding Faculty of the Year Award", "Selected as one of the "100 Most Influential Persons" in Morgantown, WV", "Selected as one of the "Top Doctors of America"", "Fellow", "Idea Award", "Career Development Award", "Merit Award for the Fellows", "Nominated as the Clinician of the Year", "Nominated for the Clinician of the Year Award", "Top 99th Percentile in Customer Satisfaction", "U.S. News Top Doctor", "Pfizer/Roerig Prize", "Howard Levine, M.D., Science Award", "Research Studentship" and "National Merit Scholarship". Jame Abraham has written publications. He has 61 publications published with PubMed. The lastest publication is: 'Prospective Clinical Study of Precision Oncology in Solid Tumors.' Doctor Jame Abraham, MD is registered with Medicare.
Publications
- Exercise and dietary advice intervention for survivors of triple-negative Breast cancer: effects on body fat, physical function, quality of life, and adipokine profile.
- PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for Breast cancer therapies?
- 3-D Visualization and Non-linear Tissue Classification of Breast Tumors Using Ultrasound Elastography In Vivo.
- Linking Genetic Counseling Content to Short-Term Outcomes in Individuals at Elevated Breast Cancer Risk.
- Efficacy of solubilized vemurafenib administered via nasogastric Tube.
- Overcoming endocrine resistance in Breast cancer: role of the PI3K and the mTOR pathways.
- Nonlinear characterization of Breast cancer using multi-compression 3D ultrasound elastography in vivo.
- Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
- Research highlights: highlights from the latest articles in Cancer immunotherapy.
- Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy.
- Perception of Cancer recurrence risk: More information is better.
- Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic ...
- Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based re...
- Cognitive dysfunction in postmenopausal Breast cancer patients on aromatase inhibitors.
- Barriers to recruitment of rural patients in Cancer clinical trials.
- Initial clinical test of a Breast-PET scanner.
- Smoking behaviors among Cancer survivors: an observational clinical study.
- Biological considerations and clinical applications of new HER2-targeted agents.
- Prognostic significance of the "surprise" question in Cancer patients.
- Circulating tumor cells in the management of Breast cancer.
- Role of obesity and exercise in Breast cancer survivors.
- A population-based gene signature is predictive of Breast cancer survival and chemoresponse.
- Triple-negative Breast cancer in West Virginia.
- Building a statewide clinical trials network for Cancer care in West Virginia.
- Biological mechanisms of bevacizumab-associated adverse events.
- A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
- Role of positron-emission tomography scan in the diagnosis and management of Breast cancer.
- Transverse myelitis: amphiphysin autoimmunity paraneoplastic syndrome in a woman with Breast cancer.
- Treatment of Malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
- Cancer health disparities among Indian and Pakistani immigrants in the United States: a Surveillance, Epidemiology, and End Results-based study from 1988 to 2003.
- Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, Cancer antigen 27.29, and circulating tumor cell testing in metastatic brea...
- Cognitive dysfunction induced by chronic administration of common Cancer chemotherapeutics in rats.
- Role of tumor markers and circulating tumors cells in the management of Breast cancer.
- Adjuvant chemotherapy for Breast cancer: effects on cerebral white matter seen in diffusion tensor imaging.
- Role of MRI in screening, diagnosis and management of Breast cancer.
- Ixabepilone: a new microtubule-targeting agent for Breast cancer.
- Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with Breast cancer.
- CNS metastasis in primary Breast cancer.
- Lapatinib in the treatment of Breast cancer.
- Population-based molecular prognosis of Breast cancer by transcriptional profiling.
- Epidermal growth factor receptor as a target for Cancer therapy.
- Genomic profiling in clinical oncology. The predictive value of genomic information in Cancer management.
- Anemia and neutropenia associated with copper deficiency of unclear etiology.
- Actinic keratosis and capecitabine therapy.
- Thymic hyperplasia after adjuvant chemotherapy in Breast cancer.
- Perioperative management of a patient with May-Hegglin anomaly requiring craniotomy.
- Increased risk of brain metastases in patients with HER-2/neu-positive Breast carcinoma.
- Managing early Breast cancer: prognostic features guide choice of therapy.
- Breast and ovarian cancer genetics and prevention.
- High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model.
- Paraneoplastic neurologic syndrome associated with occult Breast cancer: a case report and review of literature.
- Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days.
- Utility of a prognostic scoring System for allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
- Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant Tumors after the administration of the glycoprotein inhibitor, XR9576.
- Radiofrequency ablation of adrenal tumors and adrenocortical Carcinoma metastases.
- Epothilones: a novel class of non-taxane microtubule-stabilizing agents.
- A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical Carcinoma: continuous infusion doxorubicin, vincrist...
- Detection of Axillary Lymph Node Metastases and Extra-Axillary Metastases With FDG PET/CT in Breast Cancer Patients Scheduled for Neoadjuvant Chemotherapy.
- Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.
- Prospective Clinical Study of Precision Oncology in Solid Tumors.
Schools
Calicut Medical College University Of Calicut
John Dempsey Hospital
University Conn School Med
National Cancer Institute
St Joseph39s College Calicut Kerala India
Procedures Preformed
Conditions Treated
- Basal Type Breast Cancer
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Breast Oncology
- Internal Medicine
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Certificate for one of Highest Accruing Principal Investigators in the Country, CTEP
- America's Top Doctors for Cancer
- Nominated as Outstanding Faculty of the Year Award
- Selected to the Gold Human Honor Society (GHHS)
- "Pink Tie Guy"
- Dean's Award for Excellence in Clinical Medicine
- Quality Award (Customer Satisfaction)
- President of India, Her Excellency, Smt. Pratibha Patil "Vaidya Bhooshan"
- Deans award for excellence in patient care
- Bonnie Wells Wilson Eminent Scholar and Distinguished Professor in Breast Cancer Research
- Best in the Class
- First Bonnie Wells Wilson Distinguished Professor and Eminent Scholar in Breast Cancer Research
- Outstanding Achievement in Medicine
- Outstanding Faculty Award
- Listed in Best Doctors in America®
- STAR Award for Customer Service
- Clinician of the Year Award
- Volunteer of the Year Award for the State of West Virginia
- Selected as one of the "Top Ten Employees"
- Nominated for the Outstanding Faculty of the Year Award
- Selected as one of the "100 Most Influential Persons" in Morgantown, WV
- Selected as one of the "Top Doctors of America"
- Fellow
- Idea Award
- Career Development Award
- Merit Award for the Fellows
- Nominated as the Clinician of the Year
- Nominated for the Clinician of the Year Award
- Top 99th Percentile in Customer Satisfaction
- U.S. News Top Doctor
- Pfizer/Roerig Prize
- Howard Levine, M.D., Science Award
- Research Studentship
- National Merit Scholarship
Education
-
National Institutes of Health Clinical Center
-
University of Connecticut
-
Calicut Medical College
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER |
|
1992723654 |
| NPPES Provider LastName |
|
ABRAHAM |
| NPPES Provider FirstName |
|
JAME |
| NPPES Provider ZIPCode |
|
26506 |
| NPPES Provider State |
|
WV |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
547.0 |
| Distinct Opioid Count |
|
4.0 |
| Opioid Claim Count |
|
96.0 |
| Percent Opioid Claims |
|
17.55 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1992723654 |
| Last Name Of The Provider |
ABRAHAM |
| First Name Of The Provider |
JAME |
| View All |
|
Similar Doctors
|
Dr. Thomas D. Ginley, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joanne C. Mortimer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricio R. Aycinena, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuvraj Choudhary, MD
|
|
|
Dr. Lindsey M. Goodman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fatima I. Adhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naresh Bumma, MD
|
|
|
Dr. Ann M. Kieber-Emmons, MD
|
|
|
Dr. Yazeed Y. Sawalha, MD
|
|
|
Dr. Brandon A. Pollak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hamid Ullah, MD
|
|
|
Dr. Brian J. Bolwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan B. LeGrand, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ming Zhou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale H. Cowan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer R. Eads, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evi Stavrou, MD
|
|
|
Dr. Paul F. Hergenroeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smitha S. Krishnamurthi, MD
This Doctor is OpenDoctor Recommended.
|
Doctor Directory | TOS | twitter | FB | Angel | blog
